Infectious Disease and Microbiology – Metagonimus yokogawai

Overview

Metagonimus yokogawai is a small intestinal trematode (fluke) that causes metagonimiasis. Human infection is usually asymptomatic, although heavier infections may produce gastrointestinal symptoms such as diarrhea, abdominal discomfort, and dyspepsia.

Humans typically acquire infection by eating raw or inadequately cooked freshwater fish containing infective metacercariae.

Classification

Genus: Metagonimus

Species: Metagonimus yokogawai

Type: Trematode helminth

Disease: Metagonimiasis

Major site of infection: Small intestine

Microbiologic Characteristics

M. yokogawai is a foodborne intestinal fluke.

The adult worms are small and inhabit the:

Small intestine

Like other trematodes, the parasite has a complex life cycle involving intermediate hosts before reaching humans.

Life Cycle

The general life cycle is:

Eggs passed in human or animal feces

↓

Development in a freshwater snail

↓

Cercariae released from the snail

↓

Cercariae penetrate freshwater fish

↓

Development into metacercariae in fish tissues

↓

Human eats raw or undercooked infected fish

↓

Metacercariae develop into adult worms in the small intestine

↓

Eggs are passed in feces

Transmission

Human infection occurs primarily through consumption of:

Raw, undercooked, or inadequately processed freshwater fish

containing:

Metacercariae

Thus, metagonimiasis is primarily a foodborne trematode infection.

Incubation Period

The incubation period is:

Not clearly established

Symptoms, when present, generally develop after the parasites mature within the intestine.

Epidemiology

Symptomatic human infection is relatively:

Rare

Cases have been reported from several regions, particularly in areas where raw or inadequately cooked freshwater fish is traditionally consumed.

Reported regions include:

• Russia

• Middle East

• India

• Indonesia

• Philippines

• China

• Japan

• Taiwan

East Asia represents an especially important endemic region for intestinal fluke infections.

Clinical Infection

The disease caused by M. yokogawai is:

Metagonimiasis

Most infections are:

Asymptomatic

Clinical severity generally increases with the number of worms present.

Gastrointestinal Manifestations

Symptomatic infection may produce:

• Diarrhea

• Abdominal discomfort

• Abdominal pain

• Dyspepsia

• Nausea

Heavy worm burdens may cause greater intestinal irritation and inflammation.

Pathogenesis

The characteristic sequence is:

Consumption of raw/undercooked infected freshwater fish

↓

Ingestion of metacercariae

↓

Development of adult flukes in small intestine

↓

Intestinal mucosal irritation

↓

Diarrhea and abdominal symptoms

Diagnosis

Diagnosis is primarily made through:

Microscopic examination of stool specimens

The characteristic finding is:

Trematode eggs in the stool

Repeated or concentrated stool examinations may improve detection when parasite burden is low.

Diagnostic Challenge

The eggs of M. yokogawai are small and can resemble those of other intestinal or hepatobiliary flukes, particularly:

Heterophyes heterophyes

Therefore, identification based solely on egg morphology may sometimes be difficult.

Treatment

The treatment described in the source is:

Praziquantel 25 mg/kg orally every 8 hours for 1 day

This provides:

3 total doses

Praziquantel is highly effective against intestinal trematode infections such as metagonimiasis.

Prevention

Prevention primarily involves:

• Thoroughly cooking freshwater fish

• Avoiding raw or inadequately cooked fish in endemic areas

• Appropriate food preparation

• Proper sanitation to reduce contamination of freshwater environments with parasite eggs

Metagonimus vs. Heterophyes

Metagonimus yokogawai

→ Small intestinal trematode

→ Raw/undercooked freshwater fish

→ Usually asymptomatic

→ Diarrhea and abdominal discomfort when symptomatic

→ Eggs detected in stool

Heterophyes heterophyes

→ Minute intestinal trematode

→ Raw, undercooked, or inadequately salted fish

→ Usually asymptomatic

→ May cause diarrhea and abdominal discomfort

→ Eggs detected in stool

The two infections can be difficult to distinguish solely by stool egg morphology.

Metagonimus vs. Clonorchis

Metagonimus yokogawai

→ Raw freshwater fish

→ Adult worms in small intestine

→ Primarily gastrointestinal symptoms

Clonorchis sinensis

→ Raw freshwater fish

→ Adult worms in biliary tract

→ Cholangitis and biliary obstruction

→ Chronic infection increases risk of cholangiocarcinoma

Thus, the exposure can be similar, but the major anatomic location differs.

High-Yield Clinical Pattern

Consumption of raw or undercooked freshwater fish

• ●

East Asian or other endemic-region exposure

• ●

Diarrhea and abdominal discomfort

• ●

Small trematode eggs in stool

→ Think Metagonimus yokogawai

→ Metagonimiasis

Exam Essentials

Organism: Metagonimus yokogawai

Type: Trematode helminth

Disease: Metagonimiasis

Major location: Small intestine

Distribution: Particularly associated with parts of Asia, with cases reported elsewhere

Transmission: Eating raw or undercooked infected freshwater fish

Infective stage for humans: Metacercariae

First intermediate host: Freshwater snail

Second intermediate host: Freshwater fish

Most infections: Asymptomatic

Major symptoms: Diarrhea, abdominal discomfort, dyspepsia

Diagnosis: Microscopic stool examination for eggs

Treatment: Praziquantel 25 mg/kg orally every 8 hours for 1 day (3 doses)

Prevention: Thoroughly cook freshwater fish

Key clinical pearl: Metagonimus yokogawai is a small intestinal fluke acquired from raw or undercooked freshwater fish. Most infections are asymptomatic, but heavier infections produce diarrhea and abdominal discomfort; diagnosis is made by detecting eggs in stool, and praziquantel is the treatment of choice.

Infectious Disease and Microbiology – Mansonella Species

Overview

Mansonella species are filarial nematodes that cause human infections collectively known as mansonellosis. Important human species include Mansonella ozzardi, M. perstans, and M. streptocerca.

Compared with several other filarial infections, Mansonella infections are generally milder and frequently asymptomatic. When symptoms occur, manifestations may include pruritus, dermatitis, hypopigmented skin lesions, edema, arthralgia, and nonspecific systemic symptoms.

Classification

Genus: Mansonella

Species:

• M. ozzardi

• M. perstans

• M. streptocerca

Type: Filarial nematode

Disease: Mansonellosis

Microbiologic Characteristics

Mansonella species are tissue-dwelling filarial nematodes.

Their life cycle involves:

Adult worms

↓

Production of microfilariae

↓

Microfilariae present in blood or skin, depending on species

↓

Uptake by an arthropod vector

↓

Development of infective larvae

↓

Transmission to another human during a subsequent bite

Incubation Period

The incubation period is:

Not clearly established

Because these infections may remain asymptomatic for prolonged periods, the interval between infection and recognizable disease can be difficult to determine.

Transmission

Mansonella species are transmitted by small biting insects.

Important vectors include:

Biting midges (Culicoides)

and, for some transmission cycles:

Blackflies (Simulium)

The specific vector differs according to the Mansonella species and geographic region.

Mansonella ozzardi

Epidemiology

M. ozzardi occurs primarily in:

• Central America

• South America

• West Indies/Caribbean

It is therefore predominantly a parasite of the:

New World

Clinical Manifestations

Many M. ozzardi infections are asymptomatic.

Symptomatic patients may develop:

• Fever

• Headache

• Pruritus

• Arthralgia

• Lymphadenopathy

• Eosinophilia

• Nonspecific skin manifestations

Microfilariae

The microfilariae of M. ozzardi circulate primarily in:

Peripheral blood

This makes examination of blood an important diagnostic approach.

Mansonella perstans

Epidemiology

M. perstans occurs predominantly in:

West and Central Africa

and has also historically been reported in parts of:

South America

Its true geographic distribution may be broader than recognized because many infections are asymptomatic or minimally symptomatic.

Clinical Manifestations

M. perstans infection is often asymptomatic but may produce:

• Pruritus

• Angioedema

• Fever

• Headache

• Arthralgia

• Abdominal discomfort

• Eosinophilia

Adult worms characteristically inhabit:

Serous body cavities and connective tissues

Microfilariae

M. perstans microfilariae circulate in:

Peripheral blood

Unlike Loa loa, their detection is not characterized by the same classic daytime periodicity.

Mansonella streptocerca

Epidemiology

M. streptocerca occurs predominantly in:

West and Central Africa

Clinical Manifestations

This species is particularly associated with:

Cutaneous disease

Possible manifestations include:

• Pruritic dermatitis

• Hypopigmented lesions

• Papular skin lesions

• Skin thickening

Because of its cutaneous manifestations, infection may resemble:

Onchocerca volvulus infection

Microfilariae

Unlike M. ozzardi and M. perstans, the microfilariae of M. streptocerca are primarily found in:

Skin

This distinction is especially important diagnostically.

Species Comparison

M. ozzardi

→ Central/South America and Caribbean

→ Microfilariae mainly in blood

M. perstans

→ Primarily Africa

→ Adult worms associated with body cavities

→ Microfilariae in blood

M. streptocerca

→ West/Central Africa

→ Cutaneous disease

→ Microfilariae primarily in skin

Clinical Infection

Overall, mansonellosis is generally considered:

Milder than many other filarial infections

A substantial proportion of infected individuals remain:

Asymptomatic

Dermatologic Disease

The source particularly emphasizes:

Hypopigmented pruritic dermatitis

This is especially relevant to M. streptocerca infection.

Patients may experience:

• Itching

• Hypopigmentation

• Papular eruptions

• Chronic localized dermatitis

Diagnosis

Diagnosis depends on the infecting species and may involve:

• Examination for microfilariae

• Skin biopsy or skin snip

• Peripheral blood examination

• Histopathology

• Serology

Blood Examination

For:

M. ozzardi

and

M. perstans

microfilariae can be detected in:

Peripheral blood

Microscopic examination of appropriately prepared blood specimens may establish the diagnosis.

Skin Examination

For:

M. streptocerca

microfilariae are primarily detected in:

Skin specimens

Histopathologic examination or examination of skin tissue can therefore be useful.

Serology

The source also lists:

Serologic testing

However, serologic assays may demonstrate cross-reactivity with other filarial infections and may not always identify the exact Mansonella species.

Treatment

The source describes a historical regimen of:

Diethylcarbamazine (DEC)

with:

50 mg on day 1

↓

100 mg on days 2 and 3

↓

50 mg every 8 hours for 3 weeks

Treatment response varies substantially among Mansonella species, so therapy should be considered species-specific rather than assuming that one regimen is equally effective for all mansonellosis.

Additional Treatment

The source identifies a possible role for:

Doxycycline

Doxycycline can be useful against filarial parasites that depend on intracellular bacterial endosymbionts called:

Wolbachia

Reduction of Wolbachia can impair the survival and reproduction of susceptible filarial worms.

Its usefulness varies among Mansonella species.

Prevention

Prevention primarily involves reducing exposure to biting insect vectors.

Measures include:

• Protective clothing

• Insect repellents

• Screening or other barriers when appropriate

• Avoiding heavy exposure to biting midges and blackflies in endemic areas

Mansonella vs. Loa loa

Mansonella

→ Biting midges/blackflies

→ Usually mild or asymptomatic

→ Blood or skin microfilariae depending on species

→ M. streptocerca causes pruritic dermatitis

Loa loa

→ Chrysops deer fly

→ Calabar swellings

→ Subconjunctival “eye worm”

→ Diurnally periodic blood microfilariae

Mansonella streptocerca vs. Onchocerca volvulus

M. streptocerca

→ Microfilariae in skin

→ Pruritic/hypopigmented dermatitis

→ Usually relatively mild

Onchocerca volvulus

→ Microfilariae in skin and ocular tissues

→ Severe pruritic dermatitis

→ Subcutaneous nodules

→ Ocular disease

→ River blindness

High-Yield Clinical Pattern

Patient from a filariasis-endemic region

• ●

Mild or asymptomatic infection

• ●

Pruritic or hypopigmented dermatitis

• ●

Microfilariae in blood or skin depending on species

→ Think Mansonella species

Exam Essentials

Genus: Mansonella

Type: Filarial nematode

Disease: Mansonellosis

Major species: M. ozzardi, M. perstans, M. streptocerca

M. ozzardi geography: Central/South America and Caribbean

M. perstans geography: Primarily Africa, with historical South American distribution

M. streptocerca geography: West and Central Africa

Vectors: Biting midges and, in some transmission cycles, blackflies

Typical severity: Usually mild or asymptomatic

Skin manifestations: Pruritus and hypopigmented dermatitis

M. ozzardi microfilariae: Blood

M. perstans microfilariae: Blood

M. streptocerca microfilariae: Skin

Diagnosis: Blood examination or skin examination depending on species, histopathology, supportive serology

Source treatment: Diethylcarbamazine

Additional treatment: Possible role for doxycycline

Prevention: Avoid bites from transmitting insects

Key clinical pearl: The most useful distinction among Mansonella species is where the microfilariae are found: M. ozzardi and M. perstans are primarily detected in blood, whereas M. streptocerca is primarily detected in the skin and can produce a pruritic, hypopigmented dermatitis resembling mild onchocerciasis.

Infectious Disease and Microbiology – Malassezia Species

Overview

Malassezia species are lipophilic yeasts that normally colonize human skin but can cause superficial and, less commonly, invasive infections. Important species include Malassezia furfur, M. pachydermatis, and M. sympodialis.

The most familiar clinical manifestation is pityriasis versicolor, formerly called tinea versicolor. Invasive infection is particularly associated with neonates, immunocompromised patients, central venous catheters, and lipid-containing total parenteral nutrition (TPN).

Classification

Genus: Malassezia

Important species:

• M. furfur

• M. pachydermatis

• M. sympodialis

Type: Lipophilic yeast

Microbiologic Characteristics

Malassezia species are:

• Yeasts

• Lipophilic

• Normal components of the cutaneous microbiota

• Particularly associated with lipid-rich areas of the skin

Because most Malassezia species require or strongly prefer external lipids for growth, laboratory culture may require:

Lipid supplementation of the culture medium

This requirement is an important microbiologic clue.

Historical Terminology

M. furfur was previously associated with the names:

Pityrosporum orbiculare

and

Pityrosporum ovale

These older names may still appear in historical literature.

Incubation Period

The incubation period is:

Unknown

Superficial disease often reflects overgrowth of an organism already present on the skin rather than acquisition followed by a clearly defined incubation period.

Epidemiology

Malassezia species have a:

Worldwide distribution

They commonly colonize human skin without producing disease.

Risk Factors for Invasive Infection

Important risk factors include:

• Total parenteral nutrition (TPN)

• Intravenous lipid emulsions

• Central venous catheters

• Prematurity

• Low birth weight

• Immunocompromised state

• Cushing syndrome

The association between Malassezia and lipid-containing intravenous therapy is particularly important.

Pityriasis Versicolor

The most common superficial infection associated with Malassezia, especially M. furfur, is:

Pityriasis versicolor

This condition was historically called:

Tinea versicolor

Despite the older name, it is caused by a yeast rather than a dermatophyte.

Clinical Manifestations

Pityriasis versicolor typically produces:

• Hypopigmented or hyperpigmented macules

• Fine scaling

• Multiple coalescing lesions

• Minimal inflammation

• Occasional mild pruritus

Commonly affected areas include:

• Upper trunk

• Chest

• Back

• Shoulders

• Neck

Pathogenesis

The organism normally exists as part of the skin microbiota.

Under favorable conditions:

Normal cutaneous colonization

↓

Increased Malassezia proliferation

↓

Transition toward pathogenic growth

↓

Superficial infection of the stratum corneum

↓

Pityriasis versicolor

Warm, humid, and lipid-rich environments can favor proliferation.

Classic Microscopic Appearance

Direct examination of skin scrapings classically demonstrates:

Short curved hyphae + clusters of yeast cells

This produces the famous appearance:

“Spaghetti and meatballs”

This is one of the most important examination associations with Malassezia.

Diagnosis of Pityriasis Versicolor

Diagnosis is often clinical and can be supported by:

• Skin scraping

• KOH preparation

• Microscopic demonstration of yeast and short hyphal elements

Culture is usually unnecessary for straightforward pityriasis versicolor.

Systemic Malassezia Infection

Although much less common, Malassezia can produce:

Fungemia and other invasive infections

These infections occur particularly in:

• Premature neonates

• Low-birth-weight infants

• Immunocompromised patients

• Patients receiving lipid-containing TPN

• Patients with central venous catheters

TPN-Associated Fungemia

A classic invasive-disease pattern is:

Central venous catheter

• ●

Lipid-rich TPN

• ●

Persistent fungemia

→ Consider Malassezia

The organism’s lipophilic nature explains its strong association with intravenous lipid emulsions.

Malassezia furfur

M. furfur can cause:

• Pityriasis versicolor

• Catheter-associated fungemia

• Systemic infection

• Peritonitis

• Rare pneumonia

Invasive disease is particularly associated with immunocompromised patients and neonates receiving intravenous lipid-containing solutions.

Peritonitis

Patients undergoing:

Continuous ambulatory peritoneal dialysis

may rarely develop Malassezia-associated:

Peritonitis

The peritoneal dialysis catheter can act as a foreign-body surface supporting persistent infection.

Malassezia pachydermatis

M. pachydermatis is particularly associated with animals, especially dogs, but can occasionally cause human infection.

The source describes systemic infection in:

Low-birth-weight infants receiving lipid emulsions through central venous catheters

Thus, neonatal intensive-care settings are an important context for recognizing this organism.

Malassezia sympodialis

M. sympodialis commonly colonizes human skin.

The source describes its role as a cause of human disease as uncertain, although Malassezia taxonomy and understanding of individual species’ clinical significance have continued to evolve.

Diagnosis of Invasive Infection

Blood Culture

Blood culture may identify the organism, but Malassezia can be difficult to recover using routine culture conditions.

Because of its lipid dependence:

Lipid-enriched culture conditions may be required

Therefore, when Malassezia fungemia is suspected, communication with the microbiology laboratory can be important.

High-Yield Diagnostic Clue

Premature neonate

• ●

Central venous catheter

• ●

Lipid-containing TPN

• ●

Unexplained fungemia

→ Think Malassezia

Treatment of Pityriasis Versicolor

Superficial pityriasis versicolor can be treated with:

Topical antifungal therapy

or, when appropriate:

Systemic azole therapy

Azole Therapy

The source describes:

Itraconazole 200 mg orally once daily for 7 days

as an effective systemic regimen.

It also describes a historical shorter regimen of:

Itraconazole 400 mg as a single dose

for some patients.

Systemic therapy is generally reserved for extensive, recurrent, or difficult-to-treat disease rather than routine limited infection.

Topical Treatment

Topical therapies are generally preferred for uncomplicated localized disease.

The source specifically lists:

Selenium sulfide 2.5%

applied once daily for approximately 30 minutes for:

2 weeks

as an effective treatment.

Topical azole antifungals are also commonly used.

Recurrence

Pityriasis versicolor can:

Recur frequently

because Malassezia remains part of the normal skin microbiota even after successful treatment.

Residual abnormalities in skin pigmentation may persist for some time after the fungal infection has been eradicated.

Treatment of Systemic Infection

Invasive Malassezia infection requires systemic antifungal therapy.

The source describes:

Intravenous azole treatment

together with:

Removal of the central venous catheter

Source Control

An especially important management principle is:

Remove the infected catheter

and, when clinically possible:

Stop or reduce lipid-containing infusions

because the catheter and lipid-rich environment can promote continued fungal growth.

Treatment Principle

Systemic Malassezia infection

↓

Systemic antifungal therapy

• ●

Central catheter removal

• ●

Address lipid-containing infusion when possible

→ Improved source control

Malassezia vs. Dermatophytes

Malassezia

→ Lipophilic yeast

→ Normal skin flora

→ Pityriasis versicolor

→ “Spaghetti and meatballs” appearance

→ Can cause TPN-associated fungemia

Dermatophytes

→ Filamentous fungi

→ Trichophyton, Microsporum, Epidermophyton

→ Cause true tinea infections

→ Infect keratinized skin, hair, and/or nails

Therefore, the historical term “tinea versicolor” can be misleading because pityriasis versicolor is not a dermatophyte infection.

High-Yield Clinical Pattern

Hypopigmented or hyperpigmented finely scaling patches on the trunk

• ●

KOH showing short hyphae and clusters of yeast

• ●

“Spaghetti and meatballs”

→ Think Malassezia furfur

→ Pityriasis versicolor

Alternative High-Yield Pattern

Premature or immunocompromised patient

• ●

Central venous catheter

• ●

Lipid-containing TPN

• ●

Fungemia

→ Think Malassezia species

Exam Essentials

Genus: Malassezia

Important species: M. furfur, M. pachydermatis, M. sympodialis

Type: Lipophilic yeast

Distribution: Worldwide

Normal habitat: Human skin

Culture requirement: Lipid supplementation may facilitate growth

Classic superficial disease: Pityriasis versicolor

Older name: Tinea versicolor

Classic microscopy: “Spaghetti and meatballs”

Systemic risk factors: Prematurity, immunosuppression, central venous catheter and lipid-containing TPN

Systemic disease: Fungemia and other catheter-associated infections

Other infections: Peritoneal dialysis-associated peritonitis and rare pneumonia

Diagnosis of superficial disease: KOH examination

Diagnosis of fungemia: Blood culture using appropriate lipid-containing conditions

Superficial treatment: Topical azoles or selenium sulfide; systemic azoles for selected cases

Invasive treatment: Systemic antifungal therapy plus catheter removal/source control

Key clinical pearl: Malassezia has two classic examination patterns: “spaghetti and meatballs” on KOH in a patient with pityriasis versicolor, and catheter-associated fungemia in a premature or immunocompromised patient receiving lipid-rich TPN.

Infectious Disease and Microbiology – Madurella Species

Overview

Madurella species are filamentous fungi that are important causes of eumycetoma, a chronic localized fungal infection involving the skin and subcutaneous tissues. The main species include Madurella grisea and Madurella mycetomatis.

These fungi are found in soil and other environmental material, particularly in tropical and subtropical areas. Infection usually follows traumatic implantation of fungal elements into the skin.

Classification

Genus: Madurella

Species: M. grisea, M. mycetomatis

Type: Filamentous fungus (mold)

Major disease: Eumycetoma

Microbiologic Characteristics

Madurella species are filamentous molds with septate hyphae.

They are environmental fungi commonly associated with:

• Soil

• Plant material

• Organic debris

Within infected tissue, fungal elements may organize into compact structures known as grains or granules, which can sometimes be seen directly in drainage from sinus tracts.

Incubation Period

The incubation period is generally:

Months

Because the infection progresses slowly, symptoms may develop gradually over a prolonged period after traumatic inoculation.

Epidemiology

Madurella fungi are widespread in nature, but symptomatic infection is relatively uncommon.

Most cases occur in:

• Tropical regions

• Subtropical regions

• Northern Africa

• Southern Asia

• Central America

Madurella mycetomatis is an especially important cause of eumycetoma in endemic regions.

Transmission

Infection usually occurs through:

Traumatic implantation of contaminated soil or plant material into the skin

Common exposures include:

• Thorn injuries

• Splinters

• Puncture wounds

• Walking barefoot in endemic areas

The foot is the most commonly affected site.

Clinical Infection

The characteristic infection caused by Madurella species is:

Eumycetoma

This is a chronic, slowly progressive infection that may involve:

• Skin

• Subcutaneous tissue

• Fascia

• Bone in advanced disease

Classic Triad of Mycetoma

The classic clinical triad is:

Subcutaneous swelling

• ●

Draining sinus tracts

• ●

Grains or granules in the discharge

This pattern is highly suggestive of mycetoma.

Madura Foot

When mycetoma involves the foot, it is commonly called:

Madura foot

The affected foot may gradually become enlarged and distorted because of chronic inflammation, fibrosis, sinus tract formation, and progressive extension into deeper tissues.

Clinical Manifestations

Possible findings include:

• Chronic localized swelling

• Subcutaneous nodules

• Multiple sinus tracts

• Purulent drainage

• Visible fungal grains

• Progressive tissue destruction

Common sites include:

• Foot

• Ankle

• Tibial region

Osteomyelitis

Advanced infection may extend into underlying bone and produce:

Osteomyelitis

Bone involvement indicates more extensive disease and can make treatment more difficult.

Pathogenesis

The typical sequence is:

Puncture wound with contaminated soil or vegetation

↓

Fungal implantation into subcutaneous tissue

↓

Chronic granulomatous inflammation

↓

Formation of fungal grains

↓

Draining sinus tracts

↓

Extension into deeper tissues

↓

Possible osteomyelitis

Diagnosis

Diagnosis can be made by:

• Culture of affected tissue

• Histopathologic examination

• Examination of grains in drainage

• Imaging when deep extension is suspected

Fungal Culture

The source emphasizes:

Isolation of the fungus from affected tissue

Culture helps identify the organism and distinguish fungal eumycetoma from bacterial actinomycetoma.

Granules

A particularly important diagnostic clue is the presence of:

Visible grains in purulent discharge

The grains may be large enough to see without microscopy.

Their appearance can help suggest the causative organism.

Histopathology

Biopsy may demonstrate:

• Chronic granulomatous inflammation

• Fungal grains

• Septate fungal hyphae

Histology is especially helpful if culture is negative or tissue involvement is extensive.

Imaging

Imaging can help determine the extent of disease and identify:

• Deep soft-tissue involvement

• Sinus tract extension

• Bone destruction

• Osteomyelitis

MRI may be particularly useful for evaluating advanced disease.

Treatment

The source lists:

Ketoconazole

as treatment.

Ketoconazole is now largely of historical importance because systemic use is limited by toxicity and the availability of safer antifungal agents.

Additional Treatment

The source also lists:

Itraconazole

Itraconazole is commonly used for eumycetoma caused by Madurella species, often for a prolonged period because the infection is chronic.

Surgical Management

Surgical treatment may include:

• Excision of localized lesions

• Debridement of infected tissue

• Removal of necrotic tissue

More extensive surgery may be necessary when there is severe soft-tissue destruction or bone involvement.

Treatment Principle

Management often requires:

Prolonged antifungal therapy

• ●

Surgical excision or debridement when needed

Long-term follow-up is important because recurrence can occur.

Prevention

Prevention focuses on reducing traumatic inoculation.

Useful measures include:

• Wearing protective footwear

• Avoiding walking barefoot in endemic areas

• Avoiding thorn and puncture injuries

• Cleaning penetrating wounds promptly

• Wearing protective gloves when handling vegetation

Eumycetoma vs. Actinomycetoma

Eumycetoma

→ Caused by fungi

→ Madurella is an important cause

→ Usually slowly progressive

→ Treated with antifungal therapy and often surgery

Actinomycetoma

→ Caused by filamentous bacteria

→ Often more inflammatory and aggressive

→ Treated primarily with antibacterial therapy

High-Yield Clinical Pattern

Patient from a tropical or subtropical region

• ●

History of puncture wound or barefoot exposure

• ●

Chronic swelling of the foot

• ●

Multiple draining sinus tracts

• ●

Visible grains in discharge

→ Think Madurella species

→ Eumycetoma / Madura foot

Exam Essentials

Organisms: Madurella grisea, Madurella mycetomatis

Type: Filamentous mold

Major disease: Eumycetoma

Environment: Soil and plant material

Geography: Tropical and subtropical regions

Transmission: Traumatic implantation

Most common site: Foot

Classic triad: Swelling + draining sinus tracts + grains

Major complication: Osteomyelitis

Diagnosis: Culture, histopathology, examination of grains

Source treatment: Ketoconazole

Additional treatment: Itraconazole and surgical removal

Prevention: Avoid puncture wounds and use protective footwear

Key clinical pearl: Madurella species classically cause eumycetoma of the foot after traumatic implantation from soil. The most important pattern is chronic swelling, draining sinus tracts, and visible fungal grains, with osteomyelitis occurring in advanced disease.

Infectious Disease and Microbiology – Human T-Lymphotropic Viruses (HTLV-1 and HTLV-2)

Overview

Human T-lymphotropic viruses HTLV-1 and HTLV-2 are enveloped retroviruses with single-stranded positive-sense RNA genomes. They infect human T lymphocytes and can establish lifelong infection.

HTLV-1 is clearly associated with several important diseases, particularly adult T-cell leukemia/lymphoma (ATLL) and HTLV-1–associated myelopathy/tropical spastic paraparesis (HAM/TSP). By contrast, HTLV-2 has not been firmly linked to a comparable specific malignant disease.

Classification

Viruses: HTLV-1 and HTLV-2

Group: Human T-lymphotropic viruses

Family: Retroviridae

Type: Retroviruses

The historical term “human T-lymphocyte virus” is still commonly used, but “human T-lymphotropic virus” is the standard modern wording.

Microbiologic Characteristics

HTLV-1 and HTLV-2 are:

• Single-stranded positive-sense RNA viruses

• Enveloped

• Retroviruses

• Capable of reverse transcription

• Able to integrate viral DNA into the host-cell genome

Like other retroviruses, they use:

Reverse transcriptase

to convert viral RNA into DNA.

Viral Replication

The general retroviral sequence is:

Viral RNA

↓

Reverse transcription

↓

Proviral DNA

↓

Integration into host genome

↓

Persistent infection of host cells

This ability to integrate into host DNA contributes to lifelong infection.

Incubation and Latency

A precise incubation period is:

Not well defined

For HTLV-1–associated diseases, the interval between infection and clinical disease can be:

Many years to decades

Only a minority of infected individuals develop major HTLV-1–associated complications.

Epidemiology

HTLV infection occurs in multiple regions worldwide.

HTLV-1 is particularly endemic in:

• Southwestern Japan

• The Caribbean

• Parts of sub-Saharan Africa

• Parts of South America

• Other geographically clustered populations

The source specifically highlights high HTLV-1 seropositivity in:

Southeastern Japanese islands and the Caribbean basin

HTLV-2 Epidemiology

HTLV-2 has been detected in several populations and has historically had a strong association with:

Injection drug use

The virus has also been identified in certain indigenous populations.

Transmission

HTLV can be transmitted through infected lymphocytes in:

• Sexual contact

• Blood exposure

• Sharing contaminated injection equipment

• Mother-to-child transmission

Mother-to-child transmission occurs especially through:

Breastfeeding

Prevention Principle

The source states that prevention resembles that used for HIV.

Important preventive measures therefore include:

• Safer-sex practices

• Avoidance of shared needles or injection equipment

• Screening of blood products where applicable

• Prevention of mother-to-child transmission in appropriate settings

HTLV-1 Infection

Major Disease Associations

HTLV-1 is associated with:

Adult T-cell leukemia/lymphoma

and

HTLV-1–associated myelopathy/tropical spastic paraparesis

Other inflammatory and infectious associations can also occur.

Adult T-Cell Leukemia/Lymphoma

Major Malignancy

One of the classic complications of HTLV-1 is:

Adult T-cell leukemia/lymphoma (ATLL)

This is a malignancy of mature T lymphocytes.

Clinical Features

ATLL may present with:

• Lymphadenopathy

• Skin lesions

• Hepatosplenomegaly

• Circulating abnormal T cells

• Immunosuppression

• Opportunistic infections

A particularly important metabolic complication is:

Hypercalcemia

High-Yield ATLL Pattern

Adult from an HTLV-1 endemic region

• ●

T-cell malignancy

• ●

Hypercalcemia

• ●

Characteristic abnormal lymphocytes

→ Think HTLV-1–associated adult T-cell leukemia/lymphoma

Flower Cells

Peripheral blood may show atypical lymphocytes with multilobulated nuclei classically called:

“Flower cells”

This is a memorable hematologic association with ATLL.

HTLV-1–Associated Myelopathy

HAM/TSP

HTLV-1 can cause a chronic progressive neurologic syndrome known as:

HTLV-1–associated myelopathy

or:

Tropical spastic paraparesis

abbreviated:

HAM/TSP

Clinical Manifestations

HAM/TSP typically causes:

• Slowly progressive weakness of both legs

• Spastic paraparesis

• Hyperreflexia

• Gait impairment

• Urinary dysfunction

• Sensory symptoms of variable severity

The condition usually evolves gradually rather than as an acute myelitis.

High-Yield Neurologic Pattern

HTLV-1 exposure

• ●

Slowly progressive bilateral leg weakness

• ●

Spasticity and hyperreflexia

• ●

Bladder dysfunction

→ Think HAM/TSP

Infective Dermatitis

The source lists:

Jamaican infectious dermatitis

This is more commonly referred to as:

HTLV-1–associated infective dermatitis

It is a chronic relapsing dermatitis, particularly recognized in children in HTLV-1 endemic areas.

Strongyloides Association

HTLV-1 infection is also clinically important because it is associated with increased susceptibility to severe or persistent:

Strongyloides stercoralis infection

This interaction can complicate treatment and increase the risk of severe strongyloidiasis.

HTLV-2

Clinical Significance

The source states that:

No disease has been conclusively causally associated with HTLV-2

HTLV-2 was initially isolated from patients with hairy-cell leukemia, but this association was not established as causal.

HTLV-2 Today

HTLV-2 infection is generally considered less pathogenic than HTLV-1.

Some neurologic or inflammatory associations have been reported, but there is no classic disease syndrome equivalent to:

HTLV-1 → ATLL or HAM/TSP

Diagnosis

The source lists:

• Cell culture

• Serology

• Antigen detection

In modern practice, diagnosis is primarily based on:

Serologic testing

with confirmatory testing when required.

Serology

Screening tests detect:

Antibodies against HTLV

Positive screening results may require confirmatory assays to distinguish:

HTLV-1

from:

HTLV-2

Molecular Testing

PCR can detect:

Proviral HTLV DNA

and may help confirm infection or distinguish HTLV-1 from HTLV-2 in selected circumstances.

Treatment

HTLV Infection Itself

The source describes treatment as:

Symptomatic

There is no standard therapy that reliably eradicates integrated HTLV infection from the body.

Management therefore focuses largely on treating:

HTLV-associated diseases

rather than eliminating the latent virus itself.

Adult T-Cell Leukemia/Lymphoma Treatment

Management of ATLL depends on its clinical subtype and severity and may involve:

• Antineoplastic chemotherapy

• Antiviral-based approaches in selected forms

• Targeted therapy

• Hematopoietic stem-cell transplantation in selected patients

This requires specialist hematology/oncology management.

HAM/TSP Treatment

Treatment is generally aimed at:

Reducing inflammation and controlling symptoms

No therapy reliably reverses established neurologic damage in all patients.

Supportive treatment may include:

• Management of spasticity

• Physical rehabilitation

• Bladder management

• Pain management

Prevention

Because HTLV spreads through infected lymphocytes, preventive strategies resemble those used for other blood-borne and sexually transmitted retroviruses.

Important measures include:

• Safer sexual practices

• Avoiding shared injection equipment

• Appropriate blood-donor screening

• Prevention of mother-to-child transmission

Breastfeeding and Transmission

Prolonged breastfeeding is an important route of:

HTLV-1 mother-to-child transmission

In endemic areas, prevention strategies may include modification or avoidance of breastfeeding when appropriate and feasible according to local recommendations.

HTLV-1 vs. HIV

HTLV-1

→ Retrovirus

→ Primarily infects T lymphocytes

→ Promotes T-cell proliferation/transformation

→ Adult T-cell leukemia/lymphoma

→ HAM/TSP

→ Often long latency

HIV

→ Retrovirus

→ Progressive destruction and dysfunction of CD4 T cells

→ Acquired immunodeficiency syndrome

→ Opportunistic infections and malignancies

Thus:

HTLV-1 tends to drive T-cell proliferation

whereas:

HIV primarily causes progressive immune deficiency

HTLV-1 vs. HTLV-2

HTLV-1

→ Strong established disease associations

→ ATLL

→ HAM/TSP

→ Infective dermatitis

→ Endemic clusters in Japan, Caribbean and other regions

HTLV-2

→ Frequently associated epidemiologically with injection drug use

→ No classic strongly established malignant syndrome comparable with HTLV-1

→ Generally lower recognized pathogenicity

High-Yield Clinical Pattern

Patient from an HTLV-1 endemic area

• ●

Adult T-cell malignancy

• ●

Hypercalcemia

→ Think HTLV-1 → Adult T-cell leukemia/lymphoma

Alternative High-Yield Pattern

Chronic progressive spastic weakness of both legs

• ●

Hyperreflexia

• ●

Bladder dysfunction

• ●

HTLV-1 exposure

→ Think HTLV-1–associated myelopathy / tropical spastic paraparesis

Exam Essentials

Viruses: HTLV-1 and HTLV-2

Family: Retroviridae

Genome: Positive-sense single-stranded RNA

Envelope: Present

Key enzyme: Reverse transcriptase

Replication: Proviral DNA integrates into host genome

Transmission: Sexual, blood exposure, shared needles, breastfeeding

HTLV-1 endemic regions: Southwestern Japan, Caribbean, parts of Africa and South America

HTLV-2 association: Injection drug use

Major HTLV-1 malignancy: Adult T-cell leukemia/lymphoma

Classic ATLL metabolic finding: Hypercalcemia

Classic ATLL blood cell: Flower cell

Major neurologic disease: HAM/TSP

Dermatologic association: HTLV-1–associated infective dermatitis

Parasitic association: Increased risk of severe/persistent Strongyloides infection

Diagnosis: Primarily serology, with confirmatory/molecular testing as needed

Treatment: Management of specific HTLV-associated disease; no routine curative antiviral eradication therapy

Prevention: Safer sex, blood/injection precautions, and prevention of mother-to-child transmission

Key clinical pearl: HTLV-1 is the retrovirus classically linked to two major examination syndromes: adult T-cell leukemia/lymphoma—often with hypercalcemia and “flower cells”—and a chronic progressive spastic paraparesis known as HAM/TSP. HTLV-2 is epidemiologically associated with injection drug use but has far weaker established disease associations.

Infectious Disease and Microbiology – Lymphocytic Choriomeningitis Virus

Overview

Lymphocytic choriomeningitis virus (LCMV) is an enveloped RNA virus belonging to the family Arenaviridae. It is a rodent-associated zoonotic virus that usually causes either an asymptomatic or mild febrile illness but can occasionally produce aseptic meningitis, meningoencephalitis, or other neurologic disease.

A characteristic diagnostic clue is marked lymphocytic pleocytosis in the cerebrospinal fluid (CSF).

Classification

Virus: Lymphocytic choriomeningitis virus

Abbreviation: LCMV

Family: Arenaviridae

Genus: Mammarenavirus

Major reservoir: House mouse

LCMV is related to other mammarenaviruses, including Lassa virus, but the clinical syndromes are substantially different.

Microbiologic Characteristics

LCMV is:

• Enveloped

• A single-stranded RNA virus

• Characterized by two RNA genome segments

• Helical in nucleocapsid organization

• An arenavirus

The two genome segments are conventionally called:

L segment

and

S segment

Genome

The source describes the genome as:

Two single-stranded, circular RNA segments

More precisely, arenaviruses possess two single-stranded RNA genome segments with an ambisense coding strategy. The genome is segmented but is not generally described as two conventional circular RNA molecules.

Incubation Period

The incubation period is generally approximately:

1–2 weeks

The exact interval can vary depending on the nature and intensity of exposure.

Epidemiology

Human LCMV infection is:

Uncommon

but the virus has a broad geographic distribution because its principal reservoir, the house mouse, is widespread.

Rodent Reservoir

House Mouse

The classic natural reservoir is:

Mus musculus

the:

Common house mouse

Chronically infected mice may shed virus in:

• Urine

• Feces

• Saliva

• Other secretions

Other Rodent Exposures

Human infection has also been associated with exposure to infected:

• Pet rodents

• Laboratory rodents

• Rodent-contaminated environments

Thus, a history of mouse or other rodent exposure is an important epidemiologic clue.

Transmission

Humans may acquire LCMV through exposure to:

Rodent urine, feces, saliva, or contaminated material

Transmission may occur through:

• Inhalation of contaminated particles

• Direct contact with rodent excreta

• Contaminated food or surfaces

• Contact of contaminated material with damaged skin or mucous membranes

Person-to-Person Transmission

Routine person-to-person transmission is not typical.

Important exceptions include:

Mother-to-fetus transmission

and rare transmission through:

Organ transplantation

These routes are particularly important because they can result in severe disease.

Clinical Infection

Many LCMV infections are:

Asymptomatic

or produce a nonspecific influenza-like illness.

When symptomatic, disease can have a biphasic pattern.

Initial Febrile Illness

The first phase may include:

• Fever

• Malaise

• Myalgia

• Headache

• Nausea or vomiting

• Loss of appetite

The source also lists:

• Adenitis

• Skin rash

These manifestations can occur but are less characteristic than the febrile and neurologic syndromes.

Neurologic Disease

Aseptic Meningitis

LCMV is a classic viral cause of:

Aseptic meningitis

Neurologic manifestations can include:

• Severe headache

• Fever

• Neck stiffness

• Photophobia

• Nausea and vomiting

Meningoencephalitis

More extensive CNS involvement can produce:

Meningoencephalitis

with manifestations such as:

• Altered mental status

• Confusion

• Neurologic abnormalities

• Seizures in severe cases

CSF Findings

Lymphocytic Pleocytosis

A particularly characteristic finding is:

Significant lymphocytic pleocytosis

in the CSF.

This means that CSF contains an increased number of white blood cells with a predominance of:

Lymphocytes

Typical CSF Pattern

LCMV meningitis may demonstrate:

Elevated CSF white blood cells

• ●

Lymphocyte predominance

• ●

Elevated protein

• ●

Glucose that may be reduced

The possibility of low CSF glucose is notable because it can complicate differentiation from bacterial, fungal, or tuberculous meningitis.

High-Yield Meningitis Pattern

Rodent exposure

• ●

Febrile illness

• ●

Aseptic meningitis

• ●

Marked lymphocytic CSF pleocytosis

→ Think LCMV

Congenital LCMV Infection

Important Clinical Association

Maternal infection during pregnancy can result in:

Congenital LCMV infection

The virus can cross the placenta and cause severe fetal CNS and ocular abnormalities.

Congenital Manifestations

Important abnormalities can include:

• Hydrocephalus

• Microcephaly

• Intracranial calcifications

• Chorioretinitis

• Visual impairment

• Neurodevelopmental abnormalities

Congenital infection is an important but often underrecognized manifestation of LCMV.

High-Yield Congenital Pattern

Maternal rodent exposure

• ●

Congenital hydrocephalus

• ●

Chorioretinitis

• ●

Intracranial abnormalities

→ Consider congenital LCMV infection

Transplant-Associated Infection

LCMV has rarely been transmitted through:

Solid-organ transplantation

In immunosuppressed transplant recipients, infection can be severe and potentially fatal.

This is a very different clinical setting from the usually self-limited infection occurring in immunocompetent individuals.

Diagnosis

The source lists:

• Cell culture

• Serology

Serology

Detection of LCMV-specific antibodies can support the diagnosis.

Serologic testing is particularly useful when interpreted together with:

Compatible neurologic disease + rodent exposure

Molecular Diagnosis

Molecular testing using:

RT-PCR

may detect viral RNA in appropriate clinical specimens, particularly in specialized/reference laboratory settings.

Cell Culture

LCMV can be isolated in cell culture, but routine clinical diagnosis generally does not depend on viral culture because specialized laboratory procedures and biosafety precautions are required.

Treatment

The source recommends:

Symptomatic treatment

For most immunocompetent patients:

Supportive care

is the mainstay of management.

Supportive Management

Treatment may include:

• Hydration

• Analgesia

• Antipyretic therapy

• Management of nausea and vomiting

• Neurologic monitoring in meningitis or encephalitis

• Seizure management when necessary

There is no established routine antiviral treatment for uncomplicated LCMV infection.

Prevention

Prevention primarily involves reducing exposure to:

Rodents and rodent excreta

Important measures include:

• Rodent control in homes

• Safe food storage

• Avoiding direct contact with wild mice

• Appropriate cleaning of rodent-contaminated environments

• Careful handling of pet and laboratory rodents

Pregnant individuals should be particularly cautious about exposure to potentially infected rodents because of the risk of congenital infection.

LCMV vs. Lassa Virus

Lymphocytic choriomeningitis virus

→ Arenavirus

→ House mouse reservoir

→ Usually mild febrile illness or aseptic meningitis

→ Marked lymphocytic CSF pleocytosis

→ Congenital CNS/ocular disease possible

→ Treatment primarily supportive

Lassa virus

→ Arenavirus

→ Mastomys multimammate rat reservoir

→ West Africa

→ Lassa hemorrhagic fever

→ Sensorineural hearing loss is an important complication

→ Ribavirin has historically been used in treatment

High-Yield Clinical Pattern

Mouse/rodent exposure

• ●

Biphasic febrile illness

• ●

Meningitis or meningoencephalitis

• ●

Marked lymphocytic pleocytosis in CSF

→ Think Lymphocytic choriomeningitis virus

Exam Essentials

Virus: Lymphocytic choriomeningitis virus (LCMV)

Family: Arenaviridae

Genus: Mammarenavirus

Genome: Two single-stranded RNA segments

Coding strategy: Ambisense

Envelope: Present

Nucleocapsid: Helical

Major reservoir: House mouse (Mus musculus)

Transmission: Exposure to infected rodent excreta/secretions

Frequency: Rare human infection

Major neurologic disease: Aseptic meningitis/meningoencephalitis

Classic CSF finding: Marked lymphocytic pleocytosis

Congenital disease: Hydrocephalus, chorioretinitis and other CNS abnormalities

Diagnosis: Serology, molecular testing such as RT-PCR, specialized viral culture

Treatment: Supportive/symptomatic

Prevention: Rodent control and avoidance of rodent excreta

Key clinical pearl: Think of LCMV when a patient with mouse or rodent exposure develops a febrile illness followed by aseptic meningitis with prominent lymphocytic CSF pleocytosis. Also remember LCMV as an important congenital infection associated particularly with hydrocephalus and chorioretinitis.

Infectious Disease and Microbiology – Loa loa

Overview

Loa loa is a filarial nematode that causes loiasis, also known as African eye worm disease. Infection is endemic in parts of Central and West Africa and is transmitted to humans by the bite of infected Chrysops deer flies.

Most infected individuals remain asymptomatic. Symptomatic disease classically produces transient angioedematous swellings called Calabar swellings and migration of an adult worm across the subconjunctival tissues of the eye.

Classification

Genus: Loa

Species: Loa loa

Type: Filarial nematode

Disease: Loiasis

Common name: African eye worm

Microbiologic Characteristics

L. loa is a:

• Tissue-dwelling filarial nematode

• Parasite transmitted by an arthropod vector

• Cause of chronic subcutaneous infection

• Producer of circulating microfilariae

Adult worms migrate through the subcutaneous tissues, whereas microfilariae circulate in the peripheral bloodstream.

Vector

The vector is an infected:

Chrysops deer fly

These flies are also called:

Deer flies or mango flies

Transmission occurs when an infected fly takes a blood meal and introduces infective larvae into the skin.

Transmission Cycle

Infected Chrysops fly bites human

↓

Infective larvae enter the skin

↓

Larvae mature into adult worms

↓

Adult worms migrate through subcutaneous tissues

↓

Females release microfilariae

↓

Microfilariae circulate in peripheral blood

↓

Another deer fly ingests microfilariae

Incubation and Development

Microfilariae may become detectable in peripheral blood several months after infection.

The source describes approximately:

4 months

as an early point at which microfilaremia or symptoms may appear.

However, symptomatic loiasis frequently develops only after:

Several years

This prolonged course reflects the chronic nature of filarial infection.

Epidemiology

Loiasis occurs primarily in:

Central and West Africa

particularly in forested regions where the Chrysops vector is present.

The source estimates that millions of people may be infected in endemic regions.

Clinical Infection

The disease caused by L. loa is:

Loiasis

Most infected people are:

Asymptomatic

When manifestations occur, they primarily result from migration of adult worms through subcutaneous tissues and the host inflammatory response.

Calabar Swellings

Classic Manifestation

One of the most characteristic findings is:

Calabar swelling

These are transient, localized areas of subcutaneous edema caused by the inflammatory response associated with migrating adult worms.

Clinical Features

Calabar swellings may:

• Appear suddenly

• Occur on different parts of the body

• Produce localized discomfort

• Cause pruritus

• Cause localized pain

• Persist temporarily and then resolve

• Recur at another location

The extremities are commonly affected.

Pathogenesis

Adult worm migrates through tissue

↓

Local inflammatory/hypersensitivity response

↓

Transient localized edema

↓

Calabar swelling

Eye Worm

Subconjunctival Migration

Another classic manifestation is migration of an:

Adult Loa loa worm across the conjunctiva

The worm may be directly visible moving beneath the conjunctival surface.

This striking finding accounts for the name:

African eye worm

Clinical Manifestations

Subconjunctival migration can cause:

• Foreign-body sensation

• Eye irritation

• Conjunctival inflammation

• Lacrimation

• Discomfort

Although dramatic, the worm’s passage across the eye is usually transient.

High-Yield Clinical Pattern

Patient from Central or West Africa

• ●

Recurrent transient localized swelling

• ●

Visible worm migrating across the conjunctiva

→ Think Loa loa

→ Diagnosis: Loiasis

Microfilariae

Diurnal Periodicity

A particularly important characteristic is:

Diurnal periodicity

Loa loa microfilariae are most abundant in peripheral blood during the:

Daytime

This corresponds with the daytime feeding behavior of the Chrysops vector.

Diagnostic Implication

Blood should therefore be collected during:

Daylight hours

Traditionally, collection around the middle of the day improves the likelihood of detecting microfilariae.

This is a major examination clue.

Diagnosis

Peripheral Blood Smear

The classic diagnostic method is:

Detection of microfilariae in peripheral blood

Because of diurnal periodicity:

Obtain a daytime blood sample.

Thick and thin blood smears can be examined microscopically.

Direct Visualization

Diagnosis may also be established by:

Visualizing an adult worm beneath the conjunctiva

This is a highly characteristic finding in the appropriate epidemiologic setting.

Tissue Examination

The parasite may occasionally be identified in:

Subcutaneous tissue

especially when a migrating adult worm is removed.

Serology

The source also lists:

Serologic testing

Serology can support the diagnosis but may have limitations in distinguishing among filarial infections, particularly in endemic areas.

Treatment

Diethylcarbamazine

The source identifies:

Diethylcarbamazine (DEC)

as the principal treatment for loiasis.

DEC has activity against:

Microfilariae

and can also have activity against:

Adult worms

Therefore, it has the potential to provide definitive treatment.

Major Treatment Danger

High Microfilarial Burden

Treatment of loiasis requires special caution because rapid killing of large numbers of microfilariae can provoke a severe inflammatory reaction.

This is particularly important in patients with:

High-grade microfilaremia

Encephalopathy

A major complication of treatment can be:

Severe encephalopathy/meningoencephalitis

which may be life-threatening.

The source particularly warns about careful supervision when microfilarial density exceeds approximately:

2,000 microfilariae/mL

The risk becomes especially concerning as microfilarial burden increases.

Treatment Principle

Before administering potent microfilaricidal therapy:

Diagnose loiasis

↓

Measure the peripheral microfilarial burden

↓

Assess risk of treatment-associated neurologic complications

↓

Select and administer therapy under appropriate supervision

This is one of the most important clinical principles in managing Loa loa infection.

Additional Treatment

The source lists:

• Ivermectin

• Albendazole

However, ivermectin requires particular caution because patients with very high Loa loa microfilaremia can develop severe or fatal neurologic adverse events following rapid microfilarial killing.

Albendazole has a slower effect on microfilarial levels and has been used in selected situations.

Surgical Removal

When an adult worm is accessible, such as beneath the conjunctiva, it may be:

Surgically extracted

Removal can relieve local symptoms but does not necessarily eliminate other adult worms or circulating microfilariae elsewhere in the body.

Loa loa and Onchocerciasis Treatment

A particularly important practical association is that Loa loa co-infection can complicate treatment programs for:

Onchocerca volvulus

Ivermectin is widely used against onchocerciasis, but a patient with heavy Loa loa microfilaremia may be at risk for severe neurologic reactions after ivermectin.

Therefore, in areas where both parasites occur:

Consider Loa loa burden before ivermectin treatment.

Loa loa vs. Onchocerca volvulus

Loa loa

→ Chrysops deer fly

→ Daytime microfilariae in blood

→ Calabar swellings

→ Eye worm crosses conjunctiva

→ DEC is an important treatment

→ High microfilarial burden creates treatment-related encephalopathy risk

Onchocerca volvulus

→ Blackfly (Simulium)

→ Microfilariae primarily in skin, not peripheral blood

→ Subcutaneous nodules

→ Dermatitis

→ Ocular disease and river blindness

→ Ivermectin is central to treatment

Loa loa vs. Wuchereria bancrofti

Loa loa

→ Chrysops deer fly

→ Diurnal blood periodicity

→ Calabar swelling

→ Subconjunctival adult worm

Wuchereria bancrofti

→ Mosquito vector

→ Classically nocturnal blood periodicity

→ Lymphatic filariasis

→ Lymphedema and elephantiasis

High-Yield Diagnostic Pattern

Central/West Africa

• ●

Chrysops deer fly exposure

• ●

Calabar swellings

• ●

Subconjunctival migrating worm

• ●

Diurnally periodic microfilariae in peripheral blood

→ Loa loa

Exam Essentials

Organism: Loa loa

Type: Filarial nematode

Disease: Loiasis

Common name: African eye worm

Geography: Central and West Africa

Vector: Chrysops deer fly

Major reservoir/host: Humans are important hosts in endemic transmission

Adult worms: Migrate through subcutaneous tissues

Classic swelling: Calabar swelling

Classic ocular manifestation: Adult worm crossing the subconjunctiva

Microfilariae: Circulate in peripheral blood

Periodicity: Diurnal

Best classic blood sampling: Daytime

Diagnosis: Peripheral blood smear, direct visualization/removal of adult worm, supportive serology

Primary source treatment: Diethylcarbamazine (DEC)

Additional source treatments: Ivermectin and albendazole

Major treatment danger: Encephalopathy with high microfilarial burden

Important ivermectin issue: Heavy Loa loa microfilaremia increases the risk of severe neurologic adverse reactions

Key clinical pearl: The classic triad for Loa loa is Central/West African exposure, recurrent Calabar swellings, and a migrating subconjunctival “eye worm.” Microfilariae demonstrate diurnal periodicity, so diagnostic blood should be obtained during the daytime. Always consider the microfilarial burden before microfilaricidal treatment because heavily infected patients can develop life-threatening encephalopathy.

Infectious Disease and Microbiology – Linguatula serrata

Overview

Linguatula serrata is a pentastomid parasite, commonly called the tongue worm, that can occasionally infect humans. Human infection is known as linguatuliasis.

The parasite primarily infects animals, while humans can become accidental hosts. One of its classic clinical presentations is infestation of the nasopharynx, producing a syndrome known as halzoun or marrara syndrome.

Taxonomy

Genus: Linguatula

Species: Linguatula serrata

The source contains the spelling “L. serrate”; the correct species name is:

L. serrata

Microbiologic Characteristics

L. serrata is a:

• Pentastomid parasite

• Commonly called a tongue worm

• Obligate parasite of vertebrate hosts

• Cause of rare zoonotic human infection

Despite the traditional term “tongue worm,” pentastomids are not true helminthic worms in the conventional taxonomic sense. They are highly specialized parasitic arthropods related to crustaceans.

Morphology

The adult parasite has an elongated, flattened appearance that resembles a tongue, accounting for the name:

Tongue worm

The life cycle includes:

Egg → larva/nymph → adult

The nymphal stage is particularly important in human infection.

Incubation Period

The incubation period is:

Not clearly established

For nasopharyngeal disease, symptoms can develop after ingestion of infective stages in contaminated or inadequately prepared animal tissues.

Epidemiology

Human linguatuliasis is uncommon but has been reported more frequently in:

• Middle Eastern regions

• Africa

Cases can also occur elsewhere where the parasite’s animal life cycle is maintained.

Animal Hosts

The parasite has a zoonotic life cycle involving various animals.

The source broadly associates pentastomid parasites with:

• Reptiles

• Birds

• Mammals

For L. serrata specifically, dogs and other canids are particularly important definitive hosts, while herbivorous mammals can serve as intermediate hosts.

Transmission to Humans

Human infection can occur through ingestion of:

Raw or inadequately cooked infected animal tissues

particularly viscera containing nymphal stages.

Exposure to parasite eggs from material contaminated by infected definitive hosts can also produce visceral infection.

Linguatuliasis

Human disease can be divided broadly into:

Nasopharyngeal linguatuliasis

and

Visceral linguatuliasis

The source particularly emphasizes the nasopharyngeal form.

Nasopharyngeal Linguatuliasis

Halzoun or Marrara Syndrome

The classic clinical syndrome is:

Halzoun

also called:

Marrara syndrome

This occurs when immature/nymphal parasites attach to or migrate within the upper respiratory and pharyngeal mucosa.

Clinical Manifestations

Nymphs may lodge in the:

• Nasopharynx

• Pharynx

• Nasal passages

• Upper airway

They can cause:

• Foreign-body sensation

• Nasal or pharyngeal irritation

• Cough

• Sneezing

• Dysphagia

• Throat discomfort

• Nasal obstruction

• Upper-airway obstruction in severe cases

Pathogenesis

The characteristic sequence is:

Ingestion of infected raw/undercooked viscera

↓

Release of nymphal parasite

↓

Attachment to nasopharyngeal mucosa

↓

Inflammation and mechanical irritation

↓

Halzoun syndrome

Visceral Linguatuliasis

Humans may also function as accidental intermediate hosts.

After ingestion of parasite eggs, larvae can penetrate the intestinal wall and migrate into internal organs, where they develop into nymphal forms.

Potential sites include:

• Liver

• Lymph nodes

• Other visceral tissues

Many visceral infections may remain asymptomatic and be discovered incidentally.

Diagnosis

The source lists:

Histologic examination of biopsy tissue

as an important diagnostic method.

Diagnosis may be established by demonstrating characteristic parasite structures in affected tissue.

Direct Identification

In nasopharyngeal disease, diagnosis may also be possible when the parasite is:

Directly visualized and removed

Identification of the recovered organism can establish the diagnosis.

Imaging

Visceral nymphs may eventually undergo degeneration and calcification.

Therefore, chronic visceral linguatuliasis may occasionally be recognized through:

Calcified lesions on imaging

although imaging findings alone are not necessarily specific.

Treatment

The primary treatment described in the source is:

Surgical or mechanical removal

This is especially appropriate for accessible parasites involving the nasopharynx.

Nasopharyngeal Disease

For halzoun:

Locate parasite

↓

Remove mechanically

↓

Relieve mucosal irritation and obstruction

Symptomatic supportive care can be provided as necessary.

Visceral Disease

Asymptomatic visceral infection may not require intervention when lesions are inaccessible and inactive.

Surgical management may be considered when a localized lesion produces significant symptoms or complications.

Prevention

Prevention centers on interrupting foodborne and zoonotic exposure.

Important measures include:

• Thoroughly cooking animal meat and viscera

• Avoiding consumption of raw infected liver or other organs

• Appropriate food hygiene

• Avoiding contamination of food or water with animal feces or secretions

High-Yield Clinical Pattern

Middle East or Africa

• ●

Consumption of raw/undercooked animal viscera

• ●

Sudden nasopharyngeal irritation or obstruction

• ●

Visible tongue-worm nymph

→ Think Linguatula serrata

→ Halzoun syndrome

Linguatula vs. Other Tissue Parasites

Linguatula serrata

→ Pentastomid/tongue worm

→ Raw animal viscera

→ Nasopharyngeal disease

→ Halzoun syndrome

→ Mechanical removal

Gnathostoma spinigerum

→ Nematode

→ Raw/undercooked fish or other intermediate/paratenic hosts

→ Migratory cutaneous swelling

→ Eosinophilia

→ Possible CNS disease

Fasciola hepatica

→ Trematode

→ Aquatic vegetation

→ Hepatic migration followed by biliary disease

→ Eosinophilia common during acute migration

Exam Essentials

Organism: Linguatula serrata

Source correction: “L. serrate” → L. serrata

Common name: Tongue worm

Type: Pentastomid parasite

Taxonomic note: Pentastomids are specialized parasitic arthropods rather than conventional helminthic worms

Distribution: More frequently reported in the Middle East and Africa

Important definitive hosts: Dogs and other canids

Human role: Accidental host

Important exposure: Raw or undercooked animal viscera

Classic disease: Nasopharyngeal linguatuliasis

Classic syndrome: Halzoun (marrara syndrome)

Major symptoms: Nasopharyngeal irritation, foreign-body sensation and possible obstruction

Other form: Visceral linguatuliasis

Diagnosis: Direct parasite identification or histologic examination

Treatment: Mechanical/surgical removal

Prevention: Thorough cooking of meat and viscera

Key clinical pearl: Think of Linguatula serrata when ingestion of raw or undercooked animal viscera is followed by acute nasopharyngeal irritation, foreign-body sensation, or obstruction. This classic presentation is called halzoun (marrara syndrome), and treatment is primarily mechanical removal of the parasite.

Infectious Disease and Microbiology – Leuconostoc Species

Overview

Leuconostoc species are Gram-positive cocci that are uncommon causes of human disease. They have a worldwide distribution and may be confused in the laboratory with Enterococcus species or viridans group streptococci.

Although isolation may occasionally represent contamination or colonization, recovery of Leuconostoc from blood cultures should be evaluated carefully, particularly because true bacteremia and infective endocarditis can occur.

A particularly important microbiologic feature is their intrinsic resistance to vancomycin.

Important Species

The source lists:

• Leuconostoc citreum

• Leuconostoc lactis

• Leuconostoc mesenteroides

• Leuconostoc paramesenteroides

• Other Leuconostoc species

Taxonomy within this group has changed over time, so some organisms found in older literature have subsequently been reassigned.

Microbiologic Characteristics

Leuconostoc species are generally:

• Gram-positive cocci

• Facultatively anaerobic rather than strictly anaerobic

• Catalase-negative

• Non-spore-forming

• Lactic acid-producing organisms

Their appearance and biochemical characteristics can lead to confusion with other catalase-negative Gram-positive cocci.

Laboratory Identification

Leuconostoc may be mistaken for:

Enterococcus species

or:

Viridans group streptococci

Accurate identification is clinically important because the antimicrobial susceptibility pattern differs substantially from that of many other Gram-positive cocci.

Vancomycin Resistance

Major High-Yield Feature

The most important antimicrobial characteristic is:

Intrinsic vancomycin resistance

Therefore:

Gram-positive coccus

• ●

Looks like Enterococcus or viridans streptococcus

• ●

Vancomycin resistant

→ Consider Leuconostoc

Clinical Importance of Vancomycin Resistance

Vancomycin is commonly used empirically for serious Gram-positive infections.

However:

Leuconostoc → intrinsically resistant to vancomycin

Thus, failure to identify the organism correctly can lead to inappropriate antimicrobial treatment.

Incubation Period

The incubation period is:

Unknown

A defined incubation period is generally not clinically useful because invasive disease is rare and frequently occurs opportunistically in patients with significant underlying risk factors.

Epidemiology

Leuconostoc species have a:

Worldwide distribution

They are widely encountered in nature and are particularly associated with:

• Plants

• Vegetables

• Fermented foods

• Dairy and food-production environments

Human invasive infection remains uncommon.

Clinical Significance

The source notes that the clinical significance of Leuconostoc species has historically been uncertain.

Isolation may sometimes represent:

Contamination

However, recovery from a normally sterile site—particularly the bloodstream—should not automatically be dismissed.

Bacteremia

Leuconostoc species have occasionally caused:

Bacteremia

The source particularly identifies cases involving:

• Newborns

• Immunocompromised patients

Risk Factors for Invasive Infection

Reported invasive disease is more likely in patients with factors such as:

• Immunosuppression

• Severe underlying illness

• Neonatal age

• Prolonged hospitalization

• Intravascular catheters

• Disrupted gastrointestinal barriers

• Previous broad-spectrum antimicrobial exposure

Because cases are rare, these associations should be interpreted in the overall clinical context.

Blood Culture Interpretation

When Leuconostoc is recovered from blood, consider:

Contaminant?

versus:

True bacteremia/endovascular infection?

Evidence favoring genuine infection includes:

• Multiple positive blood cultures

• Persistent bacteremia

• Fever or sepsis

• Immunocompromised state

• Intravascular device

• Evidence of infective endocarditis

Infective Endocarditis

Leuconostoc species are a:

Rare cause of infective endocarditis

Persistent bloodstream isolation should therefore raise concern for an endovascular focus.

Endocarditis Evaluation

Possible findings include:

• Persistent fever

• Repeated positive blood cultures

• New or changing cardiac murmur

• Valvular vegetation

• Embolic manifestations

When clinically indicated, echocardiography may be necessary to investigate for valvular infection.

High-Yield Endocarditis Pattern

Persistent blood cultures with Leuconostoc

• ●

Fever

• ●

Cardiac/endovascular findings

→ Evaluate for infective endocarditis

Do not automatically dismiss the isolate as contamination.

Diagnosis

The principal diagnostic method is:

Culture

Depending on the infection, specimens may include:

• Blood cultures

• Catheter-associated specimens

• Tissue or other normally sterile material

Correct species identification is particularly important because of the organism’s vancomycin resistance.

Treatment

Penicillin or Ampicillin

The source recommends:

Penicillin G

or:

Ampicillin

For severe infections, the source recommends:

High-dose intravenous therapy

Additional Treatment Options

The source lists:

• First-generation cephalosporins

• Clindamycin

• Imipenem

Because invasive Leuconostoc infection is uncommon, treatment should ideally be guided by:

Antimicrobial susceptibility testing

particularly in severe or endovascular disease.

Avoid Vancomycin

A central treatment principle is:

Do not rely on vancomycin for Leuconostoc.

The organism is:

Intrinsically resistant to vancomycin

This is not simply an occasional acquired resistance pattern; it is a characteristic property of the genus.

Mechanism of Vancomycin Resistance

Vancomycin normally binds to the:

D-Ala-D-Ala

terminus of peptidoglycan precursors.

Leuconostoc uses altered cell-wall precursors ending in:

D-Ala-D-Lac

which greatly reduces vancomycin binding.

This provides the basis for its characteristic intrinsic glycopeptide resistance.

Treatment Principle

For clinically significant Leuconostoc infection:

Confirm true infection

↓

Correctly identify the organism

↓

Recognize intrinsic vancomycin resistance

↓

Perform susceptibility testing

↓

Use an active agent such as penicillin/ampicillin when susceptible

↓

Evaluate persistent bacteremia for an endovascular source

Leuconostoc vs. Enterococcus

Leuconostoc

→ Gram-positive coccus

→ Catalase-negative

→ May resemble Enterococcus

→ Rare opportunistic pathogen

→ Intrinsically vancomycin resistant

Enterococcus

→ Gram-positive coccus

→ Catalase-negative

→ Common GI flora

→ Common cause of UTI, bacteremia and endocarditis

→ Vancomycin susceptibility varies; acquired VRE mechanisms are clinically important

The distinction is particularly important when a presumed “enterococcus” demonstrates unexpected vancomycin resistance.

High-Yield Clinical Pattern

Immunocompromised or neonatal patient

• ●

Gram-positive cocci in blood

• ●

Organism resembles Enterococcus/viridans streptococcus

• ●

Vancomycin resistance

→ Think Leuconostoc

Exam Essentials

Genus: Leuconostoc

Important species: L. citreum, L. lactis, L. mesenteroides, L. paramesenteroides

Morphology: Gram-positive cocci

Metabolism: Facultatively anaerobic

Catalase: Negative

Distribution: Worldwide

Incubation: Unknown

Clinical significance: Usually low pathogenicity but capable of invasive disease

Important hosts: Newborns and immunocompromised patients

Major invasive infection: Bacteremia

Endovascular infection: Rare endocarditis

Diagnostic method: Culture

Laboratory confusion: Enterococcus and viridans streptococci

Source treatment: Penicillin G or ampicillin

Severe disease: High-dose IV therapy described in source

Additional source treatments: First-generation cephalosporin, clindamycin, imipenem

Major antimicrobial clue: Intrinsic vancomycin resistance

Resistance mechanism: Cell-wall precursor ending in D-Ala-D-Lac

Key clinical pearl: The classic clue for Leuconostoc is an unusual catalase-negative Gram-positive coccus that resembles Enterococcus or viridans streptococci but is intrinsically resistant to vancomycin. When repeatedly isolated from blood, particularly in a newborn or immunocompromised patient, it should be taken seriously and persistent bacteremia should prompt consideration of endocarditis.

Important Species The source lists: • Leuconostoc citreum

• Leuconostoc lactis

• Leuconostoc mesenteroides

• Leuconostoc paramesenteroides

• Other Leuconostoc species Taxonomy within this group has changed over time, so some organisms found in older literature have subsequently been reassigned.

Microbiologic Characteristics Leuconostoc species are generally: • Gram-positive cocci

• Facultatively anaerobic rather than strictly anaerobic

• Catalase-negative

• Non-spore-forming

• Lactic acid-producing organisms Their appearance and biochemical characteristics can lead to confusion with other catalase-negative Gram-positive cocci.

Laboratory Identification Leuconostoc may be mistaken for: Enterococcus species or: Viridans group streptococci Accurate identification is clinically important because the antimicrobial susceptibility pattern differs substantially from that of many other Gram-positive cocci.

Vancomycin Resistance Major High-Yield Feature The most important antimicrobial characteristic is: Intrinsic vancomycin resistance Therefore: Gram-positive coccus  ●  Looks like Enterococcus or viridans streptococcus  ●  Vancomycin resistant → Consider Leuconostoc

Clinical Importance of Vancomycin Resistance Vancomycin is commonly used empirically for serious Gram-positive infections. However: Leuconostoc → intrinsically resistant to vancomycin Thus, failure to identify the organism correctly can lead to inappropriate antimicrobial treatment.

Incubation Period The incubation period is: Unknown A defined incubation period is generally not clinically useful because invasive disease is rare and frequently occurs opportunistically in patients with significant underlying risk factors.

Epidemiology Leuconostoc species have a: Worldwide distribution They are widely encountered in nature and are particularly associated with: • Plants

• Vegetables

• Fermented foods

• Dairy and food-production environments Human invasive infection remains uncommon.

Clinical Significance The source notes that the clinical significance of Leuconostoc species has historically been uncertain. Isolation may sometimes represent: Contamination However, recovery from a normally sterile site—particularly the bloodstream—should not automatically be dismissed.

Bacteremia Leuconostoc species have occasionally caused: Bacteremia The source particularly identifies cases involving: • Newborns

• Immunocompromised patients

Risk Factors for Invasive Infection Reported invasive disease is more likely in patients with factors such as: • Immunosuppression

• Severe underlying illness

• Neonatal age

• Prolonged hospitalization

• Intravascular catheters

• Disrupted gastrointestinal barriers

• Previous broad-spectrum antimicrobial exposure Because cases are rare, these associations should be interpreted in the overall clinical context.

Blood Culture Interpretation When Leuconostoc is recovered from blood, consider: Contaminant? versus: True bacteremia/endovascular infection? Evidence favoring genuine infection includes: • Multiple positive blood cultures

• Persistent bacteremia

• Fever or sepsis

• Immunocompromised state

• Intravascular device

• Evidence of infective endocarditis

Infective Endocarditis Leuconostoc species are a: Rare cause of infective endocarditis Persistent bloodstream isolation should therefore raise concern for an endovascular focus.

Endocarditis Evaluation Possible findings include: • Persistent fever

• Repeated positive blood cultures

• New or changing cardiac murmur

• Valvular vegetation

• Embolic manifestations When clinically indicated, echocardiography may be necessary to investigate for valvular infection.

High-Yield Endocarditis Pattern Persistent blood cultures with Leuconostoc  ●  Fever  ●  Cardiac/endovascular findings → Evaluate for infective endocarditis Do not automatically dismiss the isolate as contamination.

Diagnosis The principal diagnostic method is: Culture Depending on the infection, specimens may include: • Blood cultures

• Catheter-associated specimens

• Tissue or other normally sterile material Correct species identification is particularly important because of the organism’s vancomycin resistance.

Treatment Penicillin or Ampicillin The source recommends: Penicillin G or: Ampicillin For severe infections, the source recommends: High-dose intravenous therapy

Additional Treatment Options The source lists: • First-generation cephalosporins

• Clindamycin

• Imipenem Because invasive Leuconostoc infection is uncommon, treatment should ideally be guided by: Antimicrobial susceptibility testing particularly in severe or endovascular disease.

Avoid Vancomycin A central treatment principle is: Do not rely on vancomycin for Leuconostoc. The organism is: Intrinsically resistant to vancomycin This is not simply an occasional acquired resistance pattern; it is a characteristic property of the genus.

Mechanism of Vancomycin Resistance Vancomycin normally binds to the: D-Ala-D-Ala terminus of peptidoglycan precursors. Leuconostoc uses altered cell-wall precursors ending in: D-Ala-D-Lac which greatly reduces vancomycin binding. This provides the basis for its characteristic intrinsic glycopeptide resistance.

Treatment Principle For clinically significant Leuconostoc infection: Confirm true infection ↓ Correctly identify the organism ↓ Recognize intrinsic vancomycin resistance ↓ Perform susceptibility testing ↓ Use an active agent such as penicillin/ampicillin when susceptible ↓ Evaluate persistent bacteremia for an endovascular source

Leuconostoc vs. Enterococcus Leuconostoc → Gram-positive coccus

→ Catalase-negative

→ May resemble Enterococcus

→ Rare opportunistic pathogen

→ Intrinsically vancomycin resistant Enterococcus → Gram-positive coccus

→ Catalase-negative

→ Common GI flora

→ Common cause of UTI, bacteremia and endocarditis

→ Vancomycin susceptibility varies; acquired VRE mechanisms are clinically important The distinction is particularly important when a presumed “enterococcus” demonstrates unexpected vancomycin resistance.

High-Yield Clinical Pattern Immunocompromised or neonatal patient  ●  Gram-positive cocci in blood  ●  Organism resembles Enterococcus/viridans streptococcus  ●  Vancomycin resistance → Think Leuconostoc

Exam Essentials Genus: Leuconostoc

Important species: L. citreum, L. lactis, L. mesenteroides, L. paramesenteroides

Morphology: Gram-positive cocci

Metabolism: Facultatively anaerobic

Catalase: Negative

Distribution: Worldwide

Incubation: Unknown

Clinical significance: Usually low pathogenicity but capable of invasive disease

Important hosts: Newborns and immunocompromised patients

Major invasive infection: Bacteremia

Endovascular infection: Rare endocarditis

Diagnostic method: Culture

Laboratory confusion: Enterococcus and viridans streptococci

Source treatment: Penicillin G or ampicillin

Severe disease: High-dose IV therapy described in source

Additional source treatments: First-generation cephalosporin, clindamycin, imipenem

Major antimicrobial clue: Intrinsic vancomycin resistance

Resistance mechanism: Cell-wall precursor ending in D-Ala-D-Lac

Key clinical pearl: The classic clue for Leuconostoc is an unusual catalase-negative Gram-positive coccus that resembles Enterococcus or viridans streptococci but is intrinsically resistant to vancomycin. When repeatedly isolated from blood, particularly in a newborn or immunocompromised patient, it should be taken seriously and persistent bacteremia should prompt consideration of endocarditis.

Infectious Disease and Microbiology – Balamuthia mandrillaris

Overview

Balamuthia mandrillaris is a free-living amoeba that causes a rare but extremely serious central nervous system infection known as granulomatous amebic encephalitis (GAE).

Older literature referred to the organism as a leptomyxid amoeba or “leptomyxid species.” Human infection is uncommon but occurs worldwide and is frequently recognized only at an advanced stage or, historically, postmortem.

⸻

Taxonomy

Current name: Balamuthia mandrillaris

Older terminology: Leptomyxid amoeba

Other medically important free-living amoebae include:

• Naegleria fowleri

• Acanthamoeba species

These organisms can all involve the CNS but differ substantially in their epidemiology and clinical presentation.

⸻

Microbiologic Characteristics

B. mandrillaris is a:

• Free-living amoeba

• Environmental organism

• Protozoan pathogen

• Cause of subacute or chronic granulomatous CNS infection

It exists primarily in:

Trophozoite and cyst forms

Both forms may be demonstrated in infected tissue.

⸻

Environmental Reservoir

Balamuthia is associated particularly with:

Soil and dust

Unlike many conventional infectious agents, it does not require a human host to complete its normal environmental existence.

⸻

Transmission

Human infection is thought to occur primarily when the organism enters through:

Broken or traumatized skin

or possibly through:

Inhalation into the respiratory tract

The organism may subsequently disseminate hematogenously to the:

Central nervous system

⸻

Incubation Period

The precise incubation period is:

Unknown

Disease typically evolves much more slowly than the rapidly progressive meningoencephalitis caused by Naegleria fowleri.

⸻

Epidemiology

Balamuthia mandrillaris infection is:

• Worldwide

• Extremely rare

• Frequently fatal

• Capable of affecting both immunocompromised and immunocompetent individuals

Thus, absence of obvious immunosuppression does not exclude balamuthiasis.

⸻

Granulomatous Amebic Encephalitis

Major Infection

The major manifestation is:

Granulomatous amebic encephalitis (GAE)

This is a progressive inflammatory and destructive infection of the brain.

⸻

Clinical Course

Unlike the explosive course of Naegleria infection, Balamuthia GAE generally has a:

Subacute to chronic course

Symptoms can progress over:

Weeks to months

before severe neurologic deterioration occurs.

⸻

Neurologic Manifestations

Patients may develop:

• Headache

• Fever

• Altered mental status

• Behavioral or personality changes

• Seizures

• Focal neurologic deficits

• Ataxia

• Cranial nerve abnormalities

• Progressive loss of consciousness

The nonspecific presentation can make early diagnosis difficult.

⸻

Cutaneous Disease

An important clue preceding CNS disease can be:

Chronic skin lesions

These may appear before neurologic manifestations and can provide an opportunity for earlier recognition and biopsy.

Skin lesions may occur particularly on the:

• Face

• Central facial region

• Extremities

⸻

High-Yield Clinical Pattern

Chronic unusual skin lesion

Weeks to months later

Progressive neurologic symptoms

Brain lesions/encephalitis

→ Consider Balamuthia mandrillaris

⸻

Diagnosis

The source lists:

CSF evaluation

as part of the diagnostic assessment.

However, definitive diagnosis can be challenging and may require examination of:

• Brain tissue

• Skin biopsy specimens

• CSF

• Other involved tissue

⸻

Immunologic Methods

The source describes:

• Direct immunofluorescence

• Immunoblot

These techniques can help distinguish Balamuthia from other free-living amoebae.

⸻

Molecular Diagnosis

Molecular methods such as:

PCR

can also be used to identify Balamuthia DNA in appropriate clinical specimens.

Because the infection is rare and difficult to recognize, specialized laboratory testing is often necessary.

⸻

Histopathology

Tissue examination may demonstrate:

Amebic trophozoites and cysts

within areas of granulomatous inflammation and tissue destruction.

Recognition of these organisms in brain or skin biopsy material can be critical for diagnosis.

⸻

CSF Findings

CSF abnormalities may resemble other forms of chronic meningoencephalitis and can include:

• Pleocytosis

• Elevated protein

• Reduced or normal glucose

Routine CSF studies alone are generally insufficient to establish the specific diagnosis.

⸻

Imaging

Brain imaging may reveal:

Multiple space-occupying or enhancing lesions

which can mimic:

• Brain tumors

• Abscesses

• Tuberculosis

• Fungal infections

• Other inflammatory CNS diseases

Therefore, the diagnosis requires a high index of suspicion.

⸻

Prognosis

Historically, the prognosis has been:

Very poor

The source notes that many patients were diagnosed:

Postmortem

because of the difficulty of recognizing the infection before advanced neurologic disease developed.

⸻

Treatment

Important Update to the Source

The source states:

“There is no known effective treatment.”

This reflects the historically extremely poor prognosis, but it is too absolute for current clinical understanding.

There is no single reliably curative standardized drug, but rare survivors have been reported after prolonged multidrug therapy.

Management therefore requires expert consultation and combination treatment rather than assuming therapy is universally futile.

⸻

Treatment Principle

Treatment of confirmed or strongly suspected Balamuthia infection generally involves:

Multiple anti-amoebic/antimicrobial agents

used in combination for prolonged periods.

Because the disease is extremely rare, the optimal regimen is not firmly established, and treatment should involve infectious-disease specialists and public-health/reference experts.

⸻

Comparison of Free-Living Amoebae

Balamuthia mandrillaris

→ Soil/dust exposure

→ Skin or respiratory entry

→ Granulomatous amebic encephalitis

→ Subacute/chronic progression

→ Can affect immunocompetent patients

→ Cutaneous lesions may precede CNS disease

Acanthamoeba species

→ Environmental free-living amoeba

→ Keratitis, especially associated with contact lenses

→ Granulomatous amebic encephalitis, particularly in immunocompromised patients

→ Cutaneous disease can occur

Naegleria fowleri

→ Warm freshwater

→ Water enters the nose

→ Migrates through the cribriform plate

→ Primary amebic meningoencephalitis (PAM)

→ Rapid, fulminant disease over days

⸻

High-Yield Balamuthia vs. Naegleria

Balamuthia

→ Soil exposure

→ GAE

→ Weeks to months

→ Possible preceding skin lesion

Naegleria

→ Warm freshwater exposure

→ Nasal entry

→ PAM

→ Rapid progression over days

This difference in tempo is particularly useful diagnostically.

⸻

High-Yield Clinical Pattern

Free-living amoeba

Progressive encephalitis over weeks to months

Possible chronic skin lesion

Granulomatous brain disease

→ Think Balamuthia mandrillaris

⸻

Exam Essentials

Organism: Balamuthia mandrillaris

Older designation: Leptomyxid amoeba

Type: Free-living amoeba

Forms: Trophozoite and cyst

Distribution: Worldwide

Frequency: Extremely rare

Environmental association: Soil and dust

Incubation: Unknown

Possible entry: Skin or respiratory tract

Major disease: Granulomatous amebic encephalitis (GAE)

Clinical course: Subacute/chronic—weeks to months

Important clue: Cutaneous lesions may precede neurologic disease

Diagnosis: Tissue examination, immunofluorescence, molecular testing such as PCR, and supportive CSF evaluation

Historical problem: Many cases diagnosed postmortem

Treatment: No single reliably effective standardized therapy; multidrug regimens have produced rare survivors

Prognosis: Very poor

⸻

Key clinical pearl: Think of Balamuthia mandrillaris when progressive granulomatous encephalitis develops over weeks to months, particularly when preceded by an unexplained chronic skin lesion. Unlike Naegleria fowleri, which causes rapidly fulminant primary amebic meningoencephalitis after warm-freshwater nasal exposure, Balamuthia typically produces a slower granulomatous CNS disease.